US BROKER MOVES: AVGO upgraded at Wells Fargo; MLTX downgraded at Goldman Sachs

• Southwest Gas (SWX) upgraded to Buy at Citi; PT USD 99
• SiTime (SITM) upgraded to Equal-Weight at Barclays
• Samsara (IOT) upgraded to Outperform at BNP Paribas; PT USD 40
• Monolithic Power Systems (MPWR) upgraded to Overweight at Wells Fargo
• Millicom (TIGO) upgraded to Buy at UBS; PT USD 70
• Manhattan Associates (MANH) upgraded to Buy at Citi; PT USD 208
• Lam Research (LRCX) upgraded to Overweight at Wells Fargo; PT USD 250
• KLA Corp (KLAC) upgraded to Overweight at Wells Fargo; PT USD 1,600
• F5 Inc (FFIV) upgraded to Overweight at JPMorgan; PT USD 345
• Entegris (ENTG) upgraded to Buy at UBS; PT USD 145
• DraftKings (DKNG) upgraded to Overweight at Wells Fargo; PT USD 49
• Digital Realty (DLR) upgraded to Buy at HSBC; PT USD 193
• Dell Technologies (DELL) upgraded to Overweight at Barclays; PT USD 148
• CI&T (CINT) upgraded to Buy at UBS; PT USD 7
• Calix (CALX) upgraded to Overweight at JPMorgan; PT USD 90
• Broadcom (AVGO) upgraded to Overweight at Wells Fargo; PT USD 430
• ASML Holding ADRs (ASML) upgraded to Outperform at KGI Securities; PT USD 1,415
• Asana (ASAN) upgraded to Buy at Citi; PT USD 16
• Applied Materials (AMAT) upgraded to Overweight at Barclays; PT USD 360
• Analog Devices (ADI) upgraded to Overweight at Wells Fargo; PT USD 340
• Amplitude (AMPL) upgraded to Overweight at Morgan Stanley; PT USD 16

• VTEX (VTEX) downgraded to Neutral at UBS; PT USD 4
• Silgan Holdings (SLGN) downgraded to Sector Perform at RBC; PT USD 43
• Rocket Lab (RKLB) downgraded to Sector Weight at KeyBanc
• Nutanix (NTNX) downgraded to Equal-Weight at Barclays; PT USD 53
• MoonLake Immunotherapeutics (MLTX) downgraded to Sell at Goldman Sachs; PT USD 10
• Leslie’s (LESL) downgraded to Underweight at Morgan Stanley; PT USD 1.50
• GE HealthCare (GEHC) downgraded to Sell at UBS; PT USD 77
• Flutter Entertainment (FLUT) downgraded to Equal-Weight at Wells Fargo; PT USD 228
• Albertsons (ACI) downgraded to Underweight at Morgan Stanley; PT USD 14

• West Coast Community Bancorp (WCCB) initiated at Buy at Janney; PT USD 52
• Toyo (TOYO) initiated at Buy at HCW; PT USD 18
• Skyworks Solutions (SWKS) initiated at Sector Perform at RBC; PT USD 65
• Silicon Labs (SLAB) initiated at Sector Perform at RBC; PT USD 160
• Sandisk (SNDK) initiated at Sector Perform at RBC; PT USD 400
• RLI Corp (RLI) initiated at Equal-Weight at Wells Fargo; PT USD 62
• Rigetti Computing (RGTI) initiated at Buy at Redburn Atlantic
• Quantum Computing (QUBT) initiated at Buy at Redburn Atlantic
• Qualcomm (QCOM) initiated at Sector Perform at RBC; PT USD 180
• Nvidia (NVDA) initiated at Outperform at RBC
• Nebius Group (NBIS) initiated at Equal-Weight at Morgan Stanley; PT USD 126
• Micron Technology (MU) initiated at Outperform at RBC
• Marvell Technology (MRVL) initiated at Outperform at RBC
• LuxExperience ADRs (LUXE) initiated at Buy at B. Riley; PT USD 12
• Lattice Semiconductor (LSCC) initiated at Outperform at RBC
• Lam Research (LRCX) initiated at Outperform at RBC
• KLA Corp (KLAC) initiated at Sector Perform at RBC; PT USD 1,550
• Kinsale Capital (KNSL) initiated at Overweight at Wells Fargo; PT USD 490
• Golub Capital (GBDC) initiated at Buy at Lucid Capital Markets; PT USD 15
• Broadcom (AVGO) initiated at Sector Perform at RBC; PT USD 370
• BankUnited (BKU) initiated at Outperform at Raymond James; PT USD 51
• Astera Labs (ALAB) initiated at Outperform at RBC
• ASML Holding ADRs (ASML) initiated at Outperform at RBC
• Arm Holdings ADRs (ARM) initiated at Outperform at RBC
• Applied Materials (AMAT) initiated at Outperform at RBC
• American Financial Group (AFG) initiated at Overweight at Wells Fargo; PT USD 165
• AMD (AMD) initiated at Sector Perform at RBC; PT USD 230
• AdvanSix (ASIX) initiated at Hold at Truist; PT USD 19

The recent upgrades and downgrades from key brokerage firms reflect significant shifts in market sentiment towards specific stocks, which could impact their respective sectors. For instance, Broadcom's upgrade at Wells Fargo suggests increased confidence in its growth prospects, while MoonLake Immunotherapeutics' downgrade at Goldman Sachs indicates caution. These moves can influence investor behavior, triggering shifts in stock prices as market participants reassess valuations based on new analyst insights.